Is Avitar, Inc. (AVTI) a Buy, Sell, or Hold?
OTC : AVTI
Avitar, Inc.
$1e-05 USD
$0 (0.0%)
- Volume
- 5
- Average Volume
- 10.29K
- Market Capitalization
- $1.38K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.14
Company Overview
OTC
Cory H. Gelmon
Medical - Specialties
Healthcare
AVTI
36
CA
USD
Liquidity Metrics
-0.53
0.14
0.09
0.02
0.00
Sales & Valuation
$3.11M
0.00
0.00
0.00
-0.09
Profitability
-$0.11
-$2.26M
-72.75%
120.40%
25.07%
-129.28%
P/E Metrics
0.00
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-67.76
2/9
-$4.79M
$1.45M
$12.55M
-$2.84M
Key Metrics (TTM)
$5.17M
1.67
-3.10
0.14
25.07%
-203.85%
-1145492.45%
-129502.46%
-42 days
Company Executives
| Name | Title |
|---|---|
| Cory H. Gelmon | Chief Executive Officer, President, Treasurer & Secretary |
Poll Results
No votes yet today — be the first to share your view!
About Avitar, Inc. (OTC:AVTI) Stock
Avitar, Inc., through its subsidiaries, designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine, such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products, including medical-grade hydrophilic polyurethane foam disposables, such as wound dressings comprising Hydrasorb, a wound dressing product for exuda ... ting wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. In addition, it develops specialty wound dressings for the cardiac catheter lab market and the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures. The company markets its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales force and strategic partners, as well as through a network of distributors. Avitar, Inc. was founded in 1986 and is based in Canton, Massachusetts.
Frequently Asked Questions
-
What is the current Avitar, Inc. (AVTI) stock price?
-
Avitar, Inc.(OTC:AVTI) stock price is $1e-05 in the last trading session. During the trading session, AVTI stock reached the peak price of $0.00001 while $0.000001 was the lowest point it dropped to. The percentage change in AVTI stock occurred in the recent session was 0.0% while the dollar amount for the price change in AVTI stock was $0.
-
AVTI's industry and sector of operation?
-
The OTC listed AVTI is part of Medical - Specialties industry that operates in the broader Healthcare sector.
-
Who are the executives of AVTI?
-
Cory H. Gelmon | Chief Executive Officer, President, Treasurer & Secretary
|
|
|
| -
How many employees does AVTI have?
-
Number of AVTI employees currently stands at 36. AVTI operates from 65 Dan Road, Calgary, MA 02021, CA.
-
Link for AVTI official website?
-
Official Website of AVTI is: https://www.a-vantti.cz
-
How do I contact AVTI?
-
AVTI could be contacted at phone #781-821-2440 and can also be accessed through its website. AVTI operates from 65 Dan Road, Calgary, MA 02021, CA.
-
How many shares of AVTI are traded daily?
-
The average number of AVTI shares traded daily for last 3 months was 10.29K.
-
What is the market cap of AVTI currently?
-
The market value of AVTI currently stands at $1.38K with its latest stock price at $1e-05